文献速递瓣膜外科

撒哈拉以南非洲风湿性心脏病主动脉瓣与二尖瓣手术的当代结局

Contemporary outcomes of aortic and mitral valve surgery for rheumatic heart disease in sub-Saharan Africa.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-04-25

本研究回顾性分析了埃塞俄比亚2009至2017年240例因风湿性心脏病接受主动脉瓣和/或二尖瓣手术的连续患者,比较机械瓣、生物瓣与瓣膜修复的结局。中位随访2.3年,手术死亡2.1%,随访死亡5%,23%发生至少一次主要不良瓣膜相关事件。倾向评分校正后,生物瓣组死亡和主要不良瓣膜相关事件风险显著高于机械瓣组,修复组与机械瓣组无显著差异。

要点

  • 风湿性左心瓣膜手术围术期死亡率可接受(2.1%),但随访期主要不良瓣膜事件发生率高(23%)。
  • 生物瓣置换与较高的死亡风险(HR 8.82)和主要不良瓣膜事件风险(HR 2.71)相关。
  • 瓣膜修复与机械瓣置换在死亡和主要不良瓣膜事件风险上无显著差异。

核心结论

  • 撒哈拉以南非洲风湿性心脏病左心瓣膜手术围术期结局可接受,但随访期主要不良瓣膜相关事件发生率高。
  • 在该患者人群中,使用生物瓣与不良结局相关。

研究设计与样本

  • 回顾性队列研究,纳入2009至2017年埃塞俄比亚心脏中心240例连续风湿性心脏病患者,接受主动脉瓣和/或二尖瓣手术,手术在22次国际人道主义任务背景下完成。
  • 中位随访2.3年(四分位距0.5-4.0年),随访完整率96%。
  • 比较机械瓣植入(n=90,38%)、生物瓣植入(n=58,24%)和瓣膜修复(n=92,38%)三组结局。

主要发现

  • 患者平均年龄19±8岁,女性136例(57%)。
  • 手术死亡5例(2.1%),组间无显著差异。
  • 随访期间额外死亡11例(5%),55例(23%)发生至少1次主要不良瓣膜相关事件。

临床怎么用

  • 在撒哈拉以南非洲风湿性心脏病患者中,左心瓣膜手术围术期 outcomes 可接受,但需警惕随访期主要不良瓣膜事件。
  • 生物瓣置换在该人群中与较差结局相关,瓣膜选择时应综合考虑。
  • 瓣膜修复与机械瓣置换在随访期死亡和主要不良瓣膜事件风险上无显著差异。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Rheumatic heart disease is endemic in sub-Saharan Africa. There is a paucity of data on the outcomes of valvular surgery for rheumatic heart disease in the developing world. The objective of this study was to evaluate the outcomes of aortic and mitral valve surgery for rheumatic heart disease in Ethiopia. METHODS: Between 2009 and 2017, 240 consecutive patients with rheumatic heart disease underwent aortic and/or mitral surgery at the Cardiac Center of Ethiopia in Addis Ababa. These surgeries were performed in the context of 22 international humanitarian missions. Median follow-up was 2.3 (interquartile range, 0.5-4.0) years and 96% complete. Outcomes were compared between patients who underwent mechanical valve implantation (n = 90, 38%), bioprosthetic valve implantation (n = 58, 24%), and valve repair (n = 92, 38%). RESULTS: Mean age of patients was 19 ± 8 years, and 136 patients (57%) were female. Operative mortality occurred in 5 patients (2.1%) and was not significantly different between the groups. Eleven additional patients (5%) died at follow-up, and 55 patients (23%) had at least 1 major adverse valve-related event. Propensity score-adjusted Cox regression analysis demonstrated higher rates of death in the bioprosthetic group compared with the mechanical group (hazard ratio, 8.82; 95% confidence interval, 1.64-47.39; P = .011). Survival was not significantly different between the repair and mechanical groups (hazard ratio, 1.09; 95% confidence interval, 0.17-7.16; P = .93). Likewise, rates of major adverse valve-related event were higher in the bioprosthetic group compared with the mechanical group (hazard ratio, 2.71; 995% confidence interval, 1.13-6.49; P = .025), but not significantly different between the repair and mechanical groups (hazard ratio, 1.98; 95% confidence interval, 0.89-4.39; P = .092). CONCLUSIONS: Left-sided valve surgery for rheumatic heart disease in sub-Saharan Africa is associated with acceptable perioperative outcomes, but a high incidence of major adverse valve-related event at follow-up. The use of bioprosthetic valves is associated with poor outcomes in this patient population.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Tamirat S, Mazine A, Stevens LM, et al. Contemporary outcomes of aortic and mitral valve surgery for rheumatic heart disease in sub-Saharan Africa. J Thorac Cardiovasc Surg. 2020. PMID: 33168165. doi:10.1016/j.jtcvs.2020.02.139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。